|
|
|
|
|
|
|
Poster: 217
Visits: 82
Title: Vincristine omission, but not dose reduction, is associated with decreased survival in elderly DLBCL patients
Authors: Salma Afifi , A. Michael, M. Azimi, M. Rodriguez, Z. Zhang, K. Woo, C. Moskowitz, A. Moskowitz, A. Kumar, M. Matasar, C. Portlock, A. Zelenetz, L. Palomba, A. Noy, J. Gerecitano, S. Horwitz, D. Straus, A. Younes, P. A. Hamlin
Centre: Memorial Sloan Kettering Cancer Center
|
|
You must be registered to reply or comment.
|
|
VINCRISTINE OMISSION, BUT NOT DOSE REDUCTION, IS ASSOCIATED WITH DECREASED SURVIVAL IN ELDERLY DLBCL PATIENTS
|
|
You must be registered to reply or comment. |
|
|
|
|
|
|
Most viewed poster for this congress |
|
|
Poster: 9
Visits: 649
Title: Ibrutinib in combination with Rituximab for Relapsed Mantle Cell Lymphoma: An Update from a Phase II Clinical Trial
Authors: Michael Wang ,
Centre: The University of Texas MD Anderson Cancer Center
|
|
|
|
|
|
|
Poster most viewed in this topic |
|
|
Poster: 154
Visits: 188
Title: NR4A3 suppresses lymphomagenesis by induction of apoptosis and serves as a drug target for lymphoma therapy
Authors: Alexander Deutsch ,
Centre: Clinical Devision of Hematology
|
|
|
|